Cannabis Law Report

JULY 29, 2021

This initial export to Austria marks Avicanna’s first commercial export of psychoactive THC Cannabis Extracts into the emerging European medicinal cannabis market. Initial shipment of THC extracts into the European Union. New progressive regulation on cannabis in Colombia.

Extraction 98

Extraction Supply Chain THC Research and Development 98

Cannabis Law Report

JUNE 5, 2019

Press Release: Thailand Government Pharmaceutical Organization. The Pharmaceutical Organization, Department of Medical Affairs, signed a joint research on standard quality medical marijuana extracts for patients with chemo-allergic cancer, epilepsy, muscle contraction in patients with deteriorating nerve sheaths.

Pharmaceutical 40

Pharmaceutical Extraction Epilepsy Research and Development 40

Cannabis Law Report

JANUARY 19, 2022

Frankfurt : C4T, ISIN: CA39540L1085) (CSE: XCX) (“Greenrise Global”) a distributor of medical and CBD wellness cannabis products in Germany announces that its wholly-owned subsidiary, AMP Alternative Medical Products GmbH (“AMP”) and Little Green Pharma Ltd. HAMBURG, Germany and PERTH, Australia , Jan.

Extraction 52

Extraction Oil Research and Development Medicine 52

Cannabis Law Report

DECEMBER 15, 2021

Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NASDAQ: CGC ) has entered into an agreement to divest its subsidiary business, C³ Cannabinoid Compound Company GmbH (“C3”), to Dermapharm Holding SE (“Dermapharm”) (WKN: A2GS5D, ISIN: DE000A2GS5D8), a European pharmaceutical company headquartered in Grünwald, Germany.

Pharmaceutical 52

Pharmaceutical Cannabinoids Business Extraction 52

Canna Care Docs

OCTOBER 3, 2023

On top of overwhelming struggles or feelings, patients who have been diagnosed with a terminal illness can face a broad range of both physical and psychological effects. However, many of these pharmaceutical medications can just induce more unpleasant, debilitating effects on those who are ill.

Chronic Pain 105

Chronic Pain Clinical Trials Patients Cannabinoids 105

Cannabis Law Report

AUGUST 18, 2021

Medical cannabis investment company Seed Innovations updated the market on its portfolio company Eurox, a Germany-based, European-focussed vertically-integrated medical cannabis company, on Tuesday. Eurox’s first launch of extracts had a balanced tetrahydrocannabinol (THC) and cannabidiol (CBD) content.

Extraction 105

Extraction Pharmaceutical THC Patients 105

Cannabis Law Report

JUNE 1, 2022

(TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), a global leader in medical cannabis throughout Europe and Latin America, announces that it has entered into an agreement to acquire Pharmadrug GmbH from its parent PharmaDrug Inc. CSE:PHRX) (OTC:LMLLF).

Pharmaceutical 52

Pharmaceutical Medicine Extraction Cannabinoids 52

Cannabis Law Report

JUNE 28, 2021

Pharmaceutical and Medical Cannabis Leaders Zambon GmbH and Adven GmbH will Drive Medical Cannabis Supporting Treatments for Neurological Therapies. The aim of the agreement is to make medical cannabis treatments available to patients, with an initial focus on neurological therapies. billion 1 by 2025.

Access 105

Access Research and Development Pharmaceutical Therapy 105

Project CBD

MARCH 8, 2019

In recent years, the use of cannabis in veterinary medicine has gone from obscure concept to a mainstream issue. This explosion of interest in the use of cannabis and CBD for animals has led to the development of a multi-million dollar industry creating cannabis-based products for pets. Medical Cannabis in California.

Pets 215

Pets Legalization Hemp Extraction 215

Cannabis Law Report

JULY 2, 2021

CannaVerde Pharma is a vertically integrated medical cannabis company with core operations in Colombia, focused on delivering low-cost, pharmaceutical grade, EU-GMP compliant cannabis-based products to consumers and medical patients in Latin America and Europe. July 28th, 2021. Company Overview. Full Suite of Licenses.

Sleep 105

Sleep Pharmaceutical THC Extraction 105

United Patients Group

APRIL 18, 2023

Introduction The medical cannabis industry is booming. However, there are still many myths about cannabis that persist despite being debunked by medical professionals and researchers alike. Myth: Cannabis is just a drug. Cannabis is a plant. Myth: Cannabis is a gateway to other drugs. Myth: Cannabis is a cure-all.

Research and Development 108

Research and Development Indica Treatment Conditions 108

Cannabis Law Report

APRIL 2, 2023

Biomind Labs” or the “Company”) (NEO: BMND) (OTC: BMNDF) (FSE: 3XI), a leading biotech company focused on developing the next generation of pharmaceuticals to treat patients suffering from neurological disorders by targeting the drivers of disease, is pleased to announce that it has successfully […]

Extraction 52

Extraction Pharmaceutical Patients Business 52

Cannabis Law Report

JULY 21, 2019

ICC International Cannabis Corp. FWB: 8K51)(OTC: WLDCF) (the “Company” or “ ICC ” or “ International Cannabis”) is pleased to announce that the Company has entered into an exclusive supply and commercial rights agreement (the “Agreement”) with licensed New Zealand medical cannabis company, NUBU Pharmaceuticals (“NUBU”).

Pharmaceutical 40

Pharmaceutical THC CBD Supply Chain 40

Cannabis Law Report

JULY 19, 2019

July 18, 2019 (GLOBE NEWSWIRE) — ICC International Cannabis Corp. Under the terms of the Agreement, ICC will supply NUBU will a suite of full-spectrum pharmaceutical grade medical cannabis products including: Packaged and labelled medical cannabis including; oil/tincture and capsules in finished goods form.

Pharmaceutical 40

Pharmaceutical THC CBD Supply Chain 40

FloridaMarijuana.net

AUGUST 16, 2018

Dementia cannot be confirmed until a patient is deceased. Dementia is hard on the patient, and often harder on the family or caregivers. Pharmaceutical treatments for for Dementia often only target symptoms like pain or depression, but those medicines do not cure or prevent the disease.

Clinical Trials 184

Clinical Trials Marijuana Patients Pharmaceutical 184

United Patients Group

FEBRUARY 7, 2023

Benefits of Cannabis for Inflammation and Pain Introduction Inflammation and pain are two of the most common health issues that many people face. Cannabis has been used as medicine for thousands of years, and there are many different ways this plant can help with inflammation and pain relief by interacting with our bodies in different ways.

Cannabinoids 114

Cannabinoids Chronic Pain Terpenes THC 114

Cannabis Law Report

APRIL 29, 2022

LONDON, April 29, 2022 –( BUSINESS WIRE )–Curaleaf International (the “Company”) part of Curaleaf Holdings (CNSX:CURA), Europe’s largest vertically integrated cannabis company, is pleased to announce the successful license of the Company’s range of cannabis based medicines as extract, under the name Adven, in Malta.

Pharmaceutical 52

Pharmaceutical Medicine Extraction Patients 52

Cannabis Law Report

JANUARY 16, 2022

The government will review the Dangerous Drugs Act 1952 and the Poisons Act 1952 to regulate cannabis and ketum for medical use, Health Minister Khairy Jamaluddin said. Cannabis, or marijuana, is currently banned under the Dangerous Drugs Act that imposes extremely harsh penalties for the use of illegal narcotics.

Research and Development 98

Research and Development Pharmaceutical Epilepsy Medicine 98

United Patients Group

FEBRUARY 2, 2023

Using Cannabis For Health and Wellness Introduction Cannabis is a plant that has been used for thousands of years to treat many ailments. The first recorded use of cannabis was in 2737 BC, when Emperor Shen Nung documented its value as a medicine. But what exactly is cannabis? This is where cannabis comes in!

Blood Pressure 103

Blood Pressure Sleep Chronic Pain Digestion 103

Cannabis Law Report

SEPTEMBER 14, 2021

The new Radicle Science-OBX alliance fills an unmet need for rigorous scientific research in the cannabis industry and sets a new gold standard for CBD and minor cannabinoid product development. About Open Book Extracts. To learn more about the Radicle Science-OBX alliance, read The Movement Is On! About Radicle Science.

Extraction 52

Extraction Research and Development Clinical Trials CBD 52

Cannabis Law Report

NOVEMBER 17, 2021

. (“ZYUS”), a Canadian-based life sciences company leading scientific research and development in phyto-therapeutics, announced today that the company has launched a new THC-dominant medical cannabinoid formulation, Zylem™ 20:1, for direct sales and distribution to registered medical patients across Canada.

Cannabinoids 52

Cannabinoids Patients Research and Development Extraction 52

Cannabis Law Report

FEBRUARY 1, 2022

New softgel capsule products further expand ZYUS’ medical cannabinoid offerings and provide patients a precise method for dosing. The two Zylem™ Softgel Capsule products each have their own unique colour to provide patients with an easy way to identify and distinguish between ZYUS softgel capsule formulations.

Cannabinoids 52

Cannabinoids Patients Research and Development Media 52

The Cannigma

DECEMBER 4, 2022

Recreational cannabis is illegal in Romania. The country technically legalized medical cannabis with less than 0.2% Despite the historical use of cannabis in Romania, the plant has been illegal since 1928. Selling cannabis can mean jail time of up to 12 years. Medical cannabis in Romania. Possible penalties.

Law 59

Law Seed-To-Sale Programs Tincture 59

Greencamp

MAY 1, 2019

It took a lot of time for humanity to “rediscover” the medical potential of cannabis. Although there’s still a long way to go, cannabis has been accepted by many as a tool for treating regular nausea, but also nausea caused by chemotherapy. Nausea was actually one of the main reasons why medical cannabis became legal in some US states.

Patients 89

Patients Strains Sativa Marijuana 89

Cannabis Law Report

APRIL 29, 2022

German patients can now buy high-THC, British Columbia-grown pot products at their local pharmacies. and will send dried flower to Cantourage to process them into medical cannabis products. and will send dried flower to Cantourage to process them into medical cannabis products.

Pharmaceutical 59

Pharmaceutical Cultivation Extraction Patients 59

Canna Care Docs

JUNE 22, 2018

An Introductory Lesson on THC Basics For Medical Cannabis Patients. Cannabis, a plant that has proven to be endlessly complex is still under the microscope by researchers, patients, physicians, and society. Learning The THC Basics To Utilize It’s Many Therapeutic Benefits.

THC 66

THC Patients Blood Pressure Clinical Trials 66

Canna Care Docs

SEPTEMBER 18, 2020

You must be a legal resident of Virginia who is able to prove residency in order to apply for a Virginia medical cannabis card. Patients under the age of 18 must also have a parent or guardian registered as a caregiver on their behalf. Patients may purchase a 90 day supply of their medication.

Pharmaceutical 98

Pharmaceutical Conditions Patients Oil 98

Veriheal

FEBRUARY 1, 2022

Most of the world is aware that cannabis is wildly effective against various types of inflammation and pain. Now, cannabis has been found to help those with muscle contraction and movement issues—particularly those who have dystonia. A Look Into Dystonia Patients and Cannabis. years, give or take. times per day.

Treatment 98

Treatment Patients Cannabis Oil 98

SpeedWeed

SEPTEMBER 9, 2021

The German medical cannabis market is one of the largest in the world. This is true of both countries in the European Union (EU) and further flung spots, all hoping to export cannabis to a country, which so far has not, by design, been able to domestically source the medical cannabis consumed in the country. . Here is why.

Legalization 52

Legalization Pharmaceutical Patients Extraction 52

Cannabis Law Report

OCTOBER 26, 2021

It does worry us when cannabis companies make announcements in the same way that you might hear that a multinational oil or energy company might announce how they are providing some useful service to a small country in Africa or Asia. Tilray Expands Medical Cannabis Footprint in Europe.

Pharmaceutical 52

Pharmaceutical Research and Development Patients Access 52

FloridaMarijuana.net

AUGUST 15, 2018

Most commonly, patients report that tingling and numbness occur, usually in the hands and feet. Additionally, the ACPA reported on a clinical trial that suggests that inhaled cannabis may provide short-term relief from Neuropathy. For centuries, humans have relied on the cannabis plant for its therapeutic properties.

Chronic Pain 150

Chronic Pain Marijuana Patients Clinical Trials 150

SpeedWeed

MARCH 9, 2021

ONE of Germany’s largest pharmaceutical firms has entered the medical cannabis space with the launch of a two flower products – and six more products to follow. Hesse-based Stada, Germany’s fifth largest pharmaceutical company, announced late last year it had entered into an agreement with Canadian firm MediPharm Labs.

Chronic Pain 52

Chronic Pain Business Pharmaceutical Extraction 52

Cannabis Law Report

AUGUST 12, 2021

Since 2013, medicinal cannabis has been legalized in the Czech Republic due to the amendment to the Act on pharmaceuticals, otherwise known as Act No. The State Institute for Drug Control regulates cannabis for medical use, and one must meet predetermined and rigorously controlled requirements to use or sell the plant.

Legalization 59

Legalization Pharmaceutical Safety Extraction 59

Cannabis Law Report

MAY 29, 2019

The research will focus on the optimisation of breeding and cultivating processes and the extraction of material to assess their efficacy of medical cannabis on prostate, melanoma and other cancer cells. Here’s the press release. All intellectual property from the trials will be owned by MGC, which is funding the research.

Cultivation 40

Cultivation Pharmaceutical Clinical Trials Extraction 40

Miss Marijuana

NOVEMBER 4, 2020

The cannabis industry is growing rapidly. Luckily for you, we’ve put together a list of 10 cannabis companies worth trying out. Matter grows their cannabis in greenhouses designed for a full-spectrum effect. The brand’s growers are pharmaceutical experts who think of the user’s best needs every step of the way.

Strains 98

Strains Concentrates Extraction Pharmaceutical 98

Cannabis Law Report

AUGUST 11, 2021

TORONTO–(BUSINESS WIRE)–Heritage Cannabis Holdings Corp. The Licensing Agreement is for the commercialization of a number of Avicanna’s advanced CBD-based topical products under Heritage’s medical cannabis brands (the “Branded Products”) targeting patients registered to purchase medical cannabis in Canada.

Topical 98

Topical Research and Development Seed-To-Sale Pharmaceutical 98

MedicalJane

MAY 21, 2020

Researchers at The University of New Mexico (UNM) have conducted a series of recent studies testing the effectiveness and safety of consuming cannabis, but this is the first study they have conducted measuring the therapeutic potential of hemp oil with low THC levels. This disconnect is commonly referred to as the placebo effect. “Our

Oil 100

Oil Hemp Extraction Clinical Trials 100